Chemotherapy triggers tumor endothelial cells to suppress IGFBP7, and the upregulation of IGF1 activates the FGF4-FGFR1-ETS2 pathway and accelerates the conversion of tumor cells to chemo-resistant tumor stem-like cells (Cao et al., 2017). Here, ETS2 is linked to neoplasm.